BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8413300)

  • 1. The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site.
    Gervais FG; Chow LM; Lee JM; Branton PE; Veillette A
    Mol Cell Biol; 1993 Nov; 13(11):7112-21. PubMed ID: 8413300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unique amino-terminal domain of p56lck regulates interactions with tyrosine protein phosphatases in T lymphocytes.
    Gervais FG; Veillette A
    Mol Cell Biol; 1995 May; 15(5):2393-401. PubMed ID: 7739523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394.
    Bougeret C; Delaunay T; Romero F; Jullien P; Sabe H; Hanafusa H; Benarous R; Fischer S
    J Biol Chem; 1996 Mar; 271(13):7465-72. PubMed ID: 8631775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
    Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramolecular and extramolecular mechanisms repress the catalytic function of p56lck in resting T-lymphocytes.
    Weil R; Veillette A
    J Biol Chem; 1994 Sep; 269(36):22830-8. PubMed ID: 7521333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain.
    Joung I; Kim T; Stolz LA; Payne G; Winkler DG; Walsh CT; Strominger JL; Shin J
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5778-82. PubMed ID: 7597029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyr394 and Tyr505 are autophosphorylated in recombinant Lck protein-tyrosine kinase expressed in Escherichia coli.
    Jullien P; Bougeret C; Camoin L; Bodeus M; Durand H; Disanto JP; Fischer S; Benarous R
    Eur J Biochem; 1994 Sep; 224(2):589-96. PubMed ID: 7523116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase.
    Autero M; Saharinen J; Pessa-Morikawa T; Soula-Rothhut M; Oetken C; Gassmann M; Bergman M; Alitalo K; Burn P; Gahmberg CG
    Mol Cell Biol; 1994 Feb; 14(2):1308-21. PubMed ID: 7507203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes.
    Cloutier JF; Chow LM; Veillette A
    Mol Cell Biol; 1995 Nov; 15(11):5937-44. PubMed ID: 7565746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro.
    Ng DH; Watts JD; Aebersold R; Johnson P
    J Biol Chem; 1996 Jan; 271(3):1295-300. PubMed ID: 8576115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase.
    Prasad KV; Kapeller R; Janssen O; Repke H; Duke-Cohan JS; Cantley LC; Rudd CE
    Mol Cell Biol; 1993 Dec; 13(12):7708-17. PubMed ID: 8246987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of p56lck through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation.
    Abraham N; Veillette A
    Mol Cell Biol; 1990 Oct; 10(10):5197-206. PubMed ID: 1697929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes.
    Vogel LB; Fujita DJ
    Mol Cell Biol; 1993 Dec; 13(12):7408-17. PubMed ID: 7504174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia.
    Wright DD; Sefton BM; Kamps MP
    Mol Cell Biol; 1994 Apr; 14(4):2429-37. PubMed ID: 8139546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein.
    Reedquist KA; Fukazawa T; Druker B; Panchamoorthy G; Shoelson SE; Band H
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4135-9. PubMed ID: 7514295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.